Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE3504.3542.35 (+1.22 %)

PREV CLOSE ( ) 3462.00

OPEN PRICE ( ) 3459.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15913

TODAY'S LOW / HIGH ( )3459.60 3545.00

52 WK LOW / HIGH ( )2891.45 3589.95

NSE3504.6045.1 (+1.3 %)

PREV CLOSE( ) 3459.50

OPEN PRICE ( ) 3466.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 3504.60 (98)

VOLUME 742875

TODAY'S LOW / HIGH( ) 3466.00 3545.00

52 WK LOW / HIGH ( )2870 3590.7

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1972

Management Info

Samir Mehta - Chairman - Managing Director

Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

04Jul Torrent Pharma executes SPA to acquire
Torrent Pharmaceuticals has executed share purchase agreement (SPA) with..

04Jul Torrent Pharma surges on executing SPA
Torrent Pharmaceuticals is currently trading at Rs. 3377.45, up by 41.20..

30Jun Torrent Pharmaceuticals to acquire con
Torrent Pharmaceuticals has entered into definitive agreements to acquir..

30Jun Torrent Pharmaceuticals gains on inkin
Torrent Pharmaceuticals is currently trading at Rs. 3365.00, up by 20.60..

30Jun Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that the Company has scheduled a te..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	4740	18880
Gross Profit	6220	26100
Operating Profit	8830	36070
Net Sales	24330	96820

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE) 9386.25 (2.44%)	M.Cap ( in Cr)23465.63
Neuland Laboratories (BSE) 14496.35 (0.67%)	M.Cap ( in Cr)18598.66
Hester Biosciences (BSE) 1946.45 (4.57%)	M.Cap ( in Cr)1655.82
Concord Biotech (BSE) 1921.55 (4.55%)	M.Cap ( in Cr)20102.53
Sanofi India (BSE) 5955.65 (1.12%)	M.Cap ( in Cr)13716.23

Shareholding Pattern

	PROMOTERS	68.31%
	NON-INSTITUTION	7.03%
	MUTUAL FUNDS/UTI	5.03%
	FI/BANKS/INSURANCE	1.31%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pha...	5.41
LIC MF Healthcare F...	5.10
ICICI Pru Nifty Pha...	4.51
Nippon India Nifty ...	4.50
PGIM India Healthca...	4.08
ITI Pharma & Health...	4.03
HDFC Pharma and Hea...	3.83

Risk Disclosures on Derivatives

Smart Quotes

TORRENT PHARMACEUTICALS LTD.